Our findings are consistent with reports stating that CML stem cells maintain their survival in an oncogene-independent manner18, and support our hypothesis that Gdpd3-mediated lysophospholipid metabolism is crucial for this maintenance in vivo. Here, GDPD3 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.